- Turnstone Biologics Appoints William Waddill to its Board of Directors
- Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
- Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
- Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
- Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
More ▼
Key statistics
On Wednesday, Turnstone Biologics Corp (TSBX:NMQ) closed at 2.60, 60.00% above the 52 week low of 1.63 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.60 |
---|---|
High | 2.69 |
Low | 2.51 |
Bid | 2.61 |
Offer | 2.87 |
Previous close | 2.60 |
Average volume | 129.99k |
---|---|
Shares outstanding | 23.13m |
Free float | 20.51m |
P/E (TTM) | -- |
Market cap | 60.13m USD |
EPS (TTM) | -2.68 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼